Shaohua Li
- Hepatology top 1%
- Surgery top 5%
- Pathology and Forensic Medicine top 2%
- Epidemiology top 10%
- Oncology top 10%
- Co-authors
- Rong GuoWei WeiRutai HuiJie MeiXiaohong HuangMing ShiYan-Lu XuXinxin Zheng
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (37 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers)Cancer Mechanisms and Therapy (10 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shaohua Li
114 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 128
- Hepatology 705
- Surgery 595
- Pathology and Forensic Medicine 525
- Epidemiology 422
- Oncology 384
Countries citing papers authored by Shaohua Li
This map shows the geographic impact of Shaohua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaohua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaohua Li more than expected).
Fields of papers citing papers by Shaohua Li
This network shows the impact of papers produced by Shaohua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaohua Li. The network helps show where Shaohua Li may publish in the future.
Co-authorship network of co-authors of Shaohua Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shaohua Li. A scholar is included among the top collaborators of Shaohua Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaohua Li. Shaohua Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 13 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 27 | |
| 10 | 38 | |
| 11 | 4 | |
| 12 | 18 | |
| 13 | Progress on the Major Derivatives of Resveratrol | 1 |
| 14 | 164 | |
| 15 | 18 | |
| 16 | 56 | |
| 17 | 88 | |
| 18 | 11 | |
| 19 | 23 | |
| 20 | 62 |
About Shaohua Li
Shaohua Li is a scholar working on Hepatology, Complementary and Manual Therapy and Cancer Research, having authored 115 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers) and Cancer Mechanisms and Therapy (10 papers). The work is most often cited by research in Hepatology (705 citations), Pathology and Forensic Medicine (525 citations) and Biochemistry (168 citations). Shaohua Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Rong Guo, Wei Wei, Rutai Hui, Jie Mei, Xiaohong Huang, Ming Shi, Yan-Lu Xu, Xinxin Zheng, Lianghe Lu and Xuxia Liu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.